Observational study aimed at evaluating the use of momelotinib in patients ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-02
Trial ID
NCT07249606
Erlotinib and Momelotinib for the Treatment of Epidermal Growth Factor Receptor (EGFR) Mutated EGFR Tyrosine Kinase Inhibitor (TKI) Naive Metastatic Non-Small Cell Lung Cancer (NSCLC)
PHASE1
This study will evaluate the safety, preliminary efficacy, and pharmacokine...
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome
PHASE2
This study will assess the efficacy and safety of momelotinib in participan...
Efficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MF
PHASE3
This study is to determine the efficacy of momelotinib (MMB) versus best av...
Efficacy and Safety of Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase
PHASE1
This study is conducted in two phases. The Dose-finding Lead-in Phase, Part...
Safety Study Evaluating Twice-Daily Administration of Momelotinib in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis
PHASE1
The myeloproliferative neoplasms (MPN), most notably polycythemia vera (PV)...